Host-directed therapies in pulmonary tuberculosis: Updates on anti-inflammatory drugs
JM Cubillos-Angulo, BMF Nogueira, MB Arriaga… - Frontiers in …, 2022 - frontiersin.org
Tuberculosis (TB) is a lethal disease and remains one of the top ten causes of mortality by
an infectious disease worldwide. It can also result in significant morbidity related to …
an infectious disease worldwide. It can also result in significant morbidity related to …
Host-directed therapies for tuberculosis
EK Jeong, HJ Lee, YJ Jung - Pathogens, 2022 - mdpi.com
Tuberculosis (TB) is one of the leading causes of death worldwide, consistently threatening
public health. Conventional tuberculosis treatment requires a long-term treatment regimen …
public health. Conventional tuberculosis treatment requires a long-term treatment regimen …
Host-directed therapeutic strategies for tuberculosis
Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), remains a leading cause of
morbidity and mortality in humans worldwide. Currently, the standard treatment for TB …
morbidity and mortality in humans worldwide. Currently, the standard treatment for TB …
Host-directed therapy as a novel treatment strategy to overcome tuberculosis: targeting immune modulation
Tuberculosis (TB) is one of the leading causes of mortality and morbidity, particularly in
developing countries, presenting a major threat to the public health. The currently …
developing countries, presenting a major threat to the public health. The currently …
Opportunities and challenges for host-directed therapies in tuberculosis
Background: Tuberculosis (TB) ranks alongside the human immunodeficiency virus (HIV) as
cause of death due to an infectious disease. Recently, host-targeted therapies (HDT) have …
cause of death due to an infectious disease. Recently, host-targeted therapies (HDT) have …
[HTML][HTML] Advances in immunomodulatory strategies for host-directed therapies in combating tuberculosis
Tuberculosis (TB) maintains its infamous status regarding its detrimental effect on global
health, causing the highest mortality by a single infectious agent. The presence of resistance …
health, causing the highest mortality by a single infectious agent. The presence of resistance …
Potential of immunomodulatory agents as adjunct host-directed therapies for multidrug-resistant tuberculosis
Abstract Treatment of multidrug-resistant tuberculosis (MDR-TB) is extremely challenging
due to the virulence of the etiologic strains of Mycobacterium tuberculosis (M. tb), the …
due to the virulence of the etiologic strains of Mycobacterium tuberculosis (M. tb), the …
[HTML][HTML] Therapeutic host-directed strategies to improve outcome in tuberculosis
Abstract Bacille Calmette-Guérin (BCG) is the only licenced tuberculosis (TB) vaccine, but
has limited efficacy against pulmonary TB disease development and modest protection …
has limited efficacy against pulmonary TB disease development and modest protection …
Host directed therapies for tuberculosis: futures strategies for an ancient disease
I Palucci, G Delogu - Chemotherapy, 2018 - karger.com
The emergence and spread of drug-resistant strains of Mycobacterium tuberculosis is
worsening the global threat of tuberculosis (TB). There is a need and urgency for the …
worsening the global threat of tuberculosis (TB). There is a need and urgency for the …
Remembering the host in tuberculosis drug development
New therapeutics to augment current approaches and shorten treatment duration are of
critical importance for combating tuberculosis (TB), especially those with novel mechanisms …
critical importance for combating tuberculosis (TB), especially those with novel mechanisms …